Brief: Oncocyte Reports Q4 And Full Year 2021 Financial Results
10/03/2022 23:38
March 10 (Reuters) - Oncocyte Corp OCX.O :
* ONCOCYTE REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* Q4 LOSS PER SHARE $0.39
Source text for Eikon: ID:nGNX52fvkc
Further company coverage: OCX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insight Molecular Diagnostics
See all newsBrief: Insight Molecular Diagnostics Enters Amendment No. 2 To Merger Agreement On Sept 15, 2026
Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Insight Molecular Diagnostics Inc expected to post a loss of 24 cents a share - Earnings Preview
Insight Molecular Diagnostics Q1 loss narrows as costs drop
Brief: Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission